Clincosm LogoSign in Get a demo

clostridium difficile infection

Showing 1 - 25 of 94
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Clostridium Difficile Infection Trial in United States (Ibezapolstat, Vancomycin)

Recruiting
  • Clostridium Difficile Infection
  • Scottsdale, Arizona
  • +28 more
Jan 31, 2023

Clostridium Difficile Infection, Fecal Microbiota Transplantation Trial in Shanghai (Fecal microbiota transplantation)

Completed
  • Clostridium Difficile Infection
  • Fecal Microbiota Transplantation
  • Fecal microbiota transplantation
  • Shanghai, Shanghai, China
    Shanghai Tenth People's Hospital
Jan 27, 2023

Clostridium Difficile Infection, Infection, Communicable Diseases Trial in Canada, United States (RBX2660)

Active, not recruiting
  • Clostridium Difficile Infection
  • +2 more
  • Phoenix, Arizona
  • +50 more
Jan 11, 2023

IBD, Clostridium Difficile Infection Trial in Boston (Bezlotoxumab, Placebo, Fecal Microbiota Transplantation)

Recruiting
  • Inflammatory Bowel Diseases
  • Clostridium Difficile Infection
  • Boston, Massachusetts
    Brigham and Women's Hospital
Jan 5, 2023

Clostridium Difficile Infection Recurrence, Clostridium Difficile Infection Trial in Worcester (Fecal Microbiota

Recruiting
  • Clostridium Difficile Infection Recurrence
  • Clostridium Difficile Infection
  • Fecal Microbiota Transplantation
  • Worcester, Massachusetts
    UMass Memorial Medical Center
Dec 19, 2022

Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea Trial in Charlottesville

Recruiting
  • Clostridioides Difficile Infection
  • +3 more
  • Charlottesville, Virginia
    UVA Health Systems
Nov 2, 2022

Bezlotoxumab for Management of Clostridioides Difficile

Enrolling by invitation
  • Clostridium Difficile Infection
  • Clostridium Difficile Infection Recurrence
  • Bezlotoxumab
  • Standard CDI treatment
  • Maywood, Illinois
    Loyola University Medical Center
Nov 1, 2022

Fecal Microbiota Transplantation, Clostridium Difficile Infection, Gut Microbiome Trial in Canada, United States (None -

Recruiting
  • Fecal Microbiota Transplantation
  • +2 more
  • None - Observational
  • Los Angeles, California
  • +38 more
Oct 20, 2022

Clostridium Difficile Infection Trial in Worldwide (Clostridium difficile vaccine, Placebo)

Completed
  • Clostridium Difficile Infection
  • Clostridium difficile vaccine
  • Placebo
  • Athens, Alabama
  • +425 more
Oct 4, 2022

Clostridium Difficile Infection, Recurrent Clostridium Difficile Infection, C. Diff Trial in Canada, United States (CP101)

Completed
Has Results
  • Clostridium Difficile Infection
  • +10 more
  • CP101
  • Scottsdale, Arizona
  • +56 more
Aug 10, 2022

Clostridium Difficile Infection Trial (CB-183,315, Vancomycin, Placebo)

Completed
Has Results
  • Clostridium Difficile Infection
  • (no location specified)
Aug 19, 2022

Human Intestinal and Salivary Microbiota Biobank -

Completed
  • Clostridium Difficile Infection
  • +4 more
  • Biological sample collection
  • +2 more
  • Bari, Italy
  • +2 more
Aug 3, 2022

Clostridium Difficile Infection Trial in Canada, United States (RBX2660, Placebo)

Completed
  • Clostridium Difficile Infection
  • Athens, Alabama
  • +65 more
Jul 29, 2022

Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Acute, Lymphoma Trial in Aurora (Diet Intervention)

Recruiting
  • Leukemia, Lymphocytic, Acute
  • +3 more
  • Diet Intervention
  • Aurora, Colorado
  • +1 more
Jun 29, 2022

Clostridium Difficile Infection, Clostridioides Difficile Infection Trial in Aarhus N (Fecal microbiota transplantion (FMT),

Active, not recruiting
  • Clostridium Difficile Infection
  • Clostridioides Difficile Infection
  • Fecal microbiota transplantion (FMT)
  • Placebo
  • Aarhus N, Denmark
    Aarhus University Hospital
Jun 7, 2022

Clostridium Difficile Infection, Diarrhea Trial (kefir)

Terminated
Has Results
  • Clostridium Difficile Infection
  • Diarrhea
  • (no location specified)
May 17, 2022

Clostridium Difficile Infection Trial in Atlanta, Decatur (Microbiota Enrichment Program (MEP))

Recruiting
  • Clostridium Difficile Infection
  • Microbiota Enrichment Program (MEP)
  • Atlanta, Georgia
  • +2 more
Mar 29, 2022

Clostridium Difficile Infection Trial in Worldwide (C. difficile Toxoid Vaccine, Placebo: 0.9% normal saline)

Terminated
Has Results
  • Clostridium Difficile Infection
  • C. difficile Toxoid Vaccine
  • Placebo: 0.9% normal saline
  • Huntsville, Alabama
  • +334 more
Mar 21, 2022

Clostridium Difficile Infection Trial in Minneapolis (Fecal Microbiota Therapy (FMT), Placebo)

Recruiting
  • Clostridium Difficile Infection
  • Fecal Microbiota Therapy (FMT)
  • Placebo
  • Minneapolis, Minnesota
    Minneapolis VA Health Care System, Minneapolis, MN
Mar 3, 2022

Healthcare Associated Infection, Clostridium Difficile Infection, Infection Due to Multidrug Resistant Bacteria Trial in Detroit

Completed
Has Results
  • Healthcare Associated Infection
  • +2 more
  • Pulsed xenon ultraviolet (PX-UV) Device
  • Sham Device
  • Detroit, Michigan
    Detroit Medical Center
Feb 16, 2022

FQ Restriction for the Prevention of CDI

Enrolling by invitation
  • Clostridium Difficile
  • +2 more
  • fluoroquinolone preprescription authorization
  • Control
  • Phoenix, Arizona
  • +7 more
Mar 2, 2022

Clostridium Difficile Infection Trial in Victoria (Fidaxomicin)

Terminated
  • Clostridium Difficile Infection
  • Victoria, BC - British Columbia, Canada
    Christine Lee
Feb 23, 2022

Clostridium Difficile Infection, Ulcerative Colitis, Indeterminate Colitis Trial in Stony Brook (Fecal Microbial

Completed
  • Clostridium Difficile Infection
  • +2 more
  • Fecal Microbial Transplantation
  • Stony Brook, New York
    Stony Brook University Hospital
Feb 21, 2022

Crohn Disease, Ulcerative Colitis, Celiac Disease Trial in Hong Kong (Fecal Microbiota Transplantation)

Recruiting
  • Crohn Disease
  • +26 more
  • Fecal Microbiota Transplantation
  • Hong Kong, Shatin, Hong Kong
    The Chinese University of Hong Kong
Feb 10, 2022

COMBACTE-CDI Understanding the Burden of C. Difficile Infection

Completed
Has Results
  • Clostridium Difficile Infection
  • No intervention
  • Leeds, West Yorkshire, United Kingdom
    University of Leeds
Jan 10, 2022